Volume : 12, Issue : 10, October – 2025

Title:

DECODING DIABETES: PATHOPHYSIOLOGY, PREVENTION, AND PROGRESS

Authors :

Priti kashinath Jondhale*, Amruta Bawane, Dr. Swati P. Deshmukh

Abstract :

Diabetes and the advancements in food and nutrition needed to prevent or manage all forms of diabetes were the main topics of the systematic review. High blood sugar levels over an extended period of time are a hallmark of diabetes. Diabetes leads to numerous health issues if treatment is not received. Diabetic ketoacidosis, hyperosmolar hyperglycemia, and even mortality are examples of acute complications. Chronic kidney disease, foot ulcers, eye damage, cardiovascular disease, and stroke are examples of serious long-term health issues.Either the pancreas cannot make enough insulin, or the body cells do not react appropriately to the insulin that is produced, which results in diabetes. There are several distinct forms of diabetes mellitus, but the three main ones are type 1, type 2, and gestational diabetes. The reason is not known. Insulin resistance, a disorder in which cells do not react to insulin as intended, is the first sign of type 2 diabetes. A shortage of insulin may also arise as the illness worsens. This kind was once known as “adult-onset diabetes” or “non-insulin-dependent diabetes mellitus” (NIDDM).Diabetes can be prevented or managed by adhering to a healthy diet, low-fat, low-calorie, paleolithic, very low carbohydrate, raw foodist, and/or ketogenic diets.
Keywords: diabetes, decoding diabetes, pathophysiology, ketoacidosis etc.

Cite This Article:

Please cite this article in press Priti kashinath Jondhale et al., Decoding Diabetes: Pathophysiology, Prevention, And Progress, Indo Am. J. P. Sci, 2025; 12(10).

REFERENCES:

1. The Editors of Encyclopaedia Britannica. Diabetes Mellitus – Medical Disorder. Encyclopaedia Britannica.
2. Basina M, Watson S. Diabetes Mellitus. Reviewed by Marina Basina, MD. October 4, 2018.
3. Shiel WC Jr. Diabetes Mellitus Overview. Last editorial review: January 26, 2017.
4. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.
5. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: WHO; 2006.
6. Cheng AY, Lau DC. The Canadian Diabetes Association 2013 clinical practice guidelines – raising the bar and setting higher standards. Can J Diabetes. 2013;37:137–8.
7. American Diabetes Association. Standards of medical care in diabetes – 2010. Diabetes Care. 2010;33(Suppl 1):S11–61.
8. Asghar O, Petropoulos IN, Alam U, et al. Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance. Diabetes Care. 2014;37:2643–6.
9. Verge CF, Gianani R, Kawasaki E, et al. Predicting Type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and IA-2 autoantibodies. Diabetes. 1996;45:926–33.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81–90.
11. DeFronzo RA, Bonadonna RC, Ferrannini E, Zimmet P. Pathogenesis of NIDDM. In: Albert KGMM, Zimmet P, DeFronzo RA, editors. International Textbook of Diabetes Mellitus. 2nd ed. Chichester: Wiley; 1997. p. 635–712.
12. Kumar CR. Basic Pathology. 5th ed. Bangalore: Prism Pvt. Ltd.; 1992. p. 569–87.
13. Jun SK, Yoon YW. A new look at viruses in Type 1 diabetes. Diabetes Metab Res Rev. 2002;19:8–31.
14. Malecki MT, Klupa T. Type 2 diabetes mellitus: from genes to disease. Pharmacol Rep. 2005;57:20–32.
15. Ahrén B, Corrigan CB. Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabet Med. 1984;2:262–4.
16. World Health Organization Study Group. Prevention of Diabetes Mellitus. WHO Technical Report Series No. 844. Geneva: WHO; 1994.
17. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: NHANES III, 1988–1994. Diabetes Care. 1998;21:518–24.
18. Zimmet P. Type 2 (non–insulin-dependent) diabetes: an epidemiological overview. Diabetologia. 1982;22:399–411.
19. Christacopoulos PD, Karamanos BG, Tountas CD, et al. The prevalence of diabetes mellitus and non-diabetic glycosuria in a rural population in Greece. Diabetologia. 1975;11:A335.
20. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non–insulin-dependent diabetes. N Engl J Med. 1993;329:1988–92.
21. Ross and Wilson. Anatomy and Physiology in Health and Illness. 11th ed. Churchill Livingstone Elsevier; 2010. p. 227–9.
22. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
23. Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Administrator. 2009;22:1–18.
24. Levine R. Sulfonylureas: background development of the field. Diabetes Care. 1984;7(Suppl 1):3–7.
25. Bearse MA Jr, Han Y, Schneck ME, et al. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:3259–65.
26. Saely CH, Aczel S, Marte T, et al. Cardiovascular complications in type 2 diabetes mellitus depend on coronary angiographic state rather than diabetes status. Diabetologia. 2004;47:145–6.
27. World Health Organization. Diabetes Fact Sheet No. 312. Geneva: WHO; October 2013.
28. Kyu HH, Bachman FV, Alexander LT, et al. Physical activity and risks of breast cancer, colon cancer, diabetes, ischemic heart disease, and stroke: systematic review and dose–response meta-analysis for Global Burden of Disease Study 2013. BMJ. 2016;354:i3857.
29. Harvard School of Public Health. The Nutrition Source. Boston: Harvard School of Public Health; 2012.
30. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch Ophthalmol. 1990;108:1234–44.
31. Hotta N, Sakamoto N, Fukuda M, et al. Epalrestat can truly prevent diabetic retinopathy: a clinical double-blind study. Diabetes. 1990;39(Suppl 1):61A.
32. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–44.
33. Eriksson KF, Lindgärde F. Prevention of type 2 diabetes mellitus by diet and physical exercise: 6-year Malmö feasibility study. Diabetologia. 1991;34:891–8.
34. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
35. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221–9.
36. Kadiki OA, Reddy MR, Marzouk AA. Incidence of insulin-dependent and non–insulin-dependent diabetes (0–34 years at onset) in Benghazi, Libya. Diabetes Res Clin Pract. 1996;32:165–73.
37. World Health Organization. The World Health Report: Shaping the Future. Geneva: WHO; 2003.
38. Shaw J, Zimmet P, de Courten M, et al. Impaired fasting glucose or impaired glucose tolerance. Diabetes Care. 1999;22:399–402.
39. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS report no. 1. Arch Ophthalmol. 1985;103:1796–806.
40. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report no. 9. Ophthalmology. 1991;98(Suppl):766–85.
41. Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized trial. Arch Ophthalmol. 1985;103:1644–52.
42. American Diabetes Association. Lifestyle management: standards of medical care in diabetes – 2019. Diabetes Care. 2019;42(Suppl 1):S46–60.
43. National Institute for Health and Care Excellence (NICE). Type 2 Diabetes in Adults: Management. London: NICE; 2019.
44. Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LM. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized controlled trial. Pediatrics. 2003;112:914–22.
45. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illness. N Engl J Med. 2010;363:2611–20.
46. Fareed A, Byrd-Sellers J, Vayalapalli S, Drexler K, Phillips L. Predictors of diabetes mellitus and abnormal blood glucose in patients receiving opioid maintenance treatment. Am J Addict. 2013;22:411–6.